Company news
Lexington Biosciences Inc (OTC:LXGTF) news
Lexington Biosciences Inc news releases on 6ix. Latest, Apr 2, 2019: Lexington Biosciences Provides Update on Financial Situation
Press releases & updates
Lexington Biosciences Provides Update on Financial Situation
April 2, 2019
Lexington Biosciences Announces Termination of Private Placement
February 14, 2019
Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
November 28, 2018
Lexington Provides Q3 Corporate Review
October 23, 2018
Lexington Announces Non-Brokered Private Placement
August 27, 2018
Lexington Announces First Multicenter Clinical Study Site
August 21, 2018
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
July 25, 2018
Lexington Biosciences Announces Results of Annual General Meeting
July 2, 2018
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
June 27, 2018
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
June 11, 2018
Lexington Engages with Major Canadian University and Provides Clinical Trial Update
May 8, 2018
Lexington Announces Brokered Private Placement
May 4, 2018
Lexington Releases Audited Consolidated Financial Statements
April 29, 2018
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
March 5, 2018
Lexington Begins HeartSentry Clinical Trial
February 20, 2018
Lexington Delivers 1st Generation HeartSentry for Clinical Trials
February 13, 2018
Lexington Recieves Approval to Commence Clinical Study
January 24, 2018
Lexington Completes IRB Submission in Preparation for Clinical Study
January 18, 2018
Lexington Biosciences Announces Exercise of Warrants
January 11, 2018
Lexington Hires Medical Device Reimbursement Experts
December 7, 2017
Lexington Biosciences Engages Clinical Research Organization
November 30, 2017
Lexington Biosciences Comments on Recent Trading Activity
November 1, 2017
Lexington Biosciences Receives HeartSentry Trial Units
October 23, 2017
Lexington Biosciences Announces DTC Eligibility of LXGTF Common Shares on OTCQB
July 25, 2017
Lexington Biosciences Introduces Medical Advisory Board
July 20, 2017
OTC Markets Group Welcomes New OTCQB Companies – July 11
July 11, 2017
Lexington Biosciences Commences Trading on OTC Markets as LXGTF and Introduces Key Board Members
July 6, 2017